Home / Veterinary / Diseases and genes

Neuroaxonal Dystrophy (NAD) Spanish Water Dog

Neurological · Dog

Neuroaxonal dystrophy (NAD) is an inherited neurodegenerative disease described in the Spanish Water Dog. It is characterized by the formation of axonal spheroids (accumulation of autophagosomes) in the grey matter of the hemispheres, cerebellum, brainstem and spinal sensory pathways, with progressive degeneration and neurological signs. It is a spontaneous model of human hereditary spastic paraparesis associated with TECPR2.
Inheritance patternAutosomal recessive (OMIA:001975-9615).
Gene / MutationTECPR2 (chromosome 8): missense variant c.4009C>T (p.Arg1337Trp) in homozygosity. TECPR2 is involved in autophagy.
PenetranceHigh in homozygotes of the described families; heterozygotes are asymptomatic carriers. There are no population estimates of penetrance.
Sample type0,5 – 1 ML Sangre EDTA preferiblemente o 2 Hisopos bucales sin medio de raspado intenso
Codehhrv
Turnaround time7 days
Price52,60 €
BreedsPerro de agua español

Incidence

Exclusive to the Spanish Water Dog. Carrier frequency in the population has not been published; population data are limited.

Clinical signs

- Progressive incoordination (ataxia)\n- Loss of proprioception (limbs in abnormal position)\n- Generalized muscle weakness\n- Ataxic gait (exaggerated steps, stumbling)\n- Tremors\n- Difficulty walking on slippery surfaces\n- Slow and inexorable progression

History

Molecularly described by Hahn and colleagues (2015), who by SNP genotyping and whole-genome resequencing identified a missense variant in TECPR2 (c.4009C>T; p.Arg1337Trp) on chromosome 8, with homozygosity in affected dogs. The TECPR2 protein is involved in autophagy and its dysfunction causes the accumulation of autophagic material characteristic of the disease.

Breeder management

- Genotype the breeders\n- Do not cross carrier × carrier: 25 % affected homozygotes\n- A carrier may be crossed with a clear dog; test the offspring intended for breeding\n- Do not breed affected animals\n- Progressively replace carriers with clear descendants without narrowing the gene pool

Specialist notes

The differential diagnosis includes other hereditary neuropathies, demyelinating diseases and idiopathic neuropathies. The TECPR2 genetic test is specific. There is no curative treatment; management is supportive (physiotherapy, environmental control). Progression is slow but inexorable.

References

1. Hahn K, et al. TECPR2 associated neuroaxonal dystrophy in Spanish Water Dogs. PLoS One. 2015;10(11):e0141824. PMID: 26555167
2. Cocostîrc V, et al. An overview of canine inherited neurological disorders with known causal variants. Animals (Basel). 2023;13(22):3568. PMID: 38003185

Add to cart

Price: 52,60 € · Turnaround time: 7 days

Add to cart

← Back to the search